Other
Cigarette Smoking
0
Pipeline Programs↗
3
Active Trials↗
2
Companies Involved↗
Cigarette Smoking is an early-stage landscape with 0 programs across 2 companies. The most active players are Stealth BioTherapeutics Inc., Novartis.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
12
clinical trials
Completed7 · 58%
Recruiting2 · 17%
Unknown status1 · 8%
Not yet recruiting1 · 8%
Withdrawn1 · 8%
Clinical Trials
Trial Activity
12 trials
Project DEDUCE: Digital Envirotyping to Develop Understanding of Cigarette Smoking and the Environment
Not yet recruiting·—·Phase 4·NCT07089901·600 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)